Viewing Study NCT06523933


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-02-20 @ 4:47 PM
Study NCT ID: NCT06523933
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-26
First Post: 2024-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Distribution of Bacteria in OME After Radiotherapy For NPC.
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D010034', 'term': 'Otitis Media with Effusion'}, {'id': 'D000077274', 'term': 'Nasopharyngeal Carcinoma'}], 'ancestors': [{'id': 'D010033', 'term': 'Otitis Media'}, {'id': 'D010031', 'term': 'Otitis'}, {'id': 'D004427', 'term': 'Ear Diseases'}, {'id': 'D010038', 'term': 'Otorhinolaryngologic Diseases'}, {'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D009303', 'term': 'Nasopharyngeal Neoplasms'}, {'id': 'D010610', 'term': 'Pharyngeal Neoplasms'}, {'id': 'D010039', 'term': 'Otorhinolaryngologic Neoplasms'}, {'id': 'D006258', 'term': 'Head and Neck Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009302', 'term': 'Nasopharyngeal Diseases'}, {'id': 'D010608', 'term': 'Pharyngeal Diseases'}, {'id': 'D009057', 'term': 'Stomatognathic Diseases'}]}}, 'protocolSection': {'designModule': {'bioSpec': {'retention': 'SAMPLES_WITHOUT_DNA', 'description': 'middle ear effusion'}, 'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 234}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2024-05-12', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-07', 'completionDateStruct': {'date': '2025-05-12', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2024-07-23', 'studyFirstSubmitDate': '2024-07-10', 'studyFirstSubmitQcDate': '2024-07-23', 'lastUpdatePostDateStruct': {'date': '2024-07-26', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2024-07-26', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-11-12', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Positive Bacterial Culture Rate in Middle Ear Effusion', 'timeFrame': 'Up to 24 weeks'}], 'secondaryOutcomes': [{'measure': 'Changes in Air Pressure (Tympanogram)', 'timeFrame': 'Collected at 6, 12, 24 Weeks after Tympanocentesis', 'description': 'Tympanogram changed from type B to type A or type C.'}, {'measure': 'Eustachian Tube Dysfunction Questionnaire (ETDQ-7)', 'timeFrame': 'Collected at 6, 12, 24 Weeks after Tympanocentesis', 'description': 'The ETDQ-7 tool is used to assess the symptoms of Otitis Media With Effusion (OME), which consists of seven items with a scale of graduated responses ranging from 1 (No Problem) to 7 (Severe Problem), and 4 would correspond to a Moderate Problem. If the total score is more than 14, it is considered that there is eustachian tube dysfunction. The average post-operative ETDQ-7 score is less than 2.1 or decrease \\> 0.5 (minimal clinically important difference=0.5), it is considered that the eustachian tube function is improved.'}]}, 'oversightModule': {'isUsExport': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Otitis Media Effusion', 'Nasopharyngeal Carcinoma', 'Bacteria'], 'conditions': ['Otitis Media Effusion', 'Nasopharyngeal Carcinoma']}, 'descriptionModule': {'briefSummary': 'To observe the prognostic difference of tympanocentesis in different kinds of otitis media effusion.', 'detailedDescription': 'This study is a prospective, observational clinical study to observe the difference in prognosis of tympanocentesis in different kinds of otitis media effusion (OME), especially OME after radiotherapy for nasopharyngeal carcinoma (NPC). A total of 234 patients diagnosed with OME who are given the treatment of tympanocentesis only, including outpatient and inpatient patients, were included in the study. The middle ear effusion collected during the tympanocentesis is sent for bacterial culture. The positive rate of the effusion and the recurrence rate within 24 weeks will be compared in order to figure out whether bacterial infection is an important influencing factor for some kinds of OME in addition to eustachian tube dysfunction, which is acknowledged.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'minimumAge': '15 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients diagnosed with OME and OME after radiotherapy for NPC, who are given the treatment of tympanostomy only, including outpatient and inpatient patients, were included in the study.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* patients clinical diagnosis of OME or OME after radiotherapy for NPC (Diagnostic criteria: fluid visible in the middle ear and a type B tympanogram).\n* patients volunteered to participate in the study and signed the informed consent\n\nExclusion Criteria:\n\n* NPC recurrence or other malignant tumor after radiotherapy.\n* clear diagnosis of Eustachian ostium atresia or nasal obstruction diseases, such as severe deviated nasal septum, choanal atresia, osteoradionecrosis of skull base after radiotherapy, etc.\n* pregnant and lactating women.\n* patients with severe underlying diseases or with severe liver and kidney dysfunction.\n* patients who could not cooperate (including poor hearing and radiation encephalopathy)\n* patients with other middle ear diseases, such as middle ear cholesteatoma, osteoradionecrosis of temporal bone after radiotherapy, etc.\n* severe deglutition disorders\n* cleft palate'}, 'identificationModule': {'nctId': 'NCT06523933', 'briefTitle': 'Distribution of Bacteria in OME After Radiotherapy For NPC.', 'organization': {'class': 'OTHER', 'fullName': 'Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University'}, 'officialTitle': 'Distribution of Bacteria in Otitis Media With Effusion After Radiotherapy For Nasopharyngeal Carcinoma.', 'orgStudyIdInfo': {'id': 'SYSKY-2023-448-01'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'ON+', 'description': 'Patients with OME after NPC with a Positive Result of Bacteria Culture of Middle Ear Effusion.'}, {'label': 'ON-', 'description': 'Patients with OME after NPC with a Negative Result of Bacteria Culture of Middle Ear Effusion.'}, {'label': 'O+', 'description': 'Patients with OME with a Positive Result of Bacteria Culture of Middle Ear Effusion.'}, {'label': 'O-', 'description': 'Patients with OME with a Negative Result of Bacteria Culture of Middle Ear Effusion.'}]}, 'contactsLocationsModule': {'locations': [{'zip': '510120', 'city': 'Guangzhou', 'state': 'Guangdong', 'country': 'China', 'facility': 'Sun Yat-sen Memorial Hospital, Sun Yat-sen University', 'geoPoint': {'lat': 23.11667, 'lon': 113.25}}], 'overallOfficials': [{'name': 'Hao Xiong', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}